project id: TCGA-GBM; case submitter id: TCGA-06-A7TK; analyte type: DNA; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.83; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.16; rna integrity number: 8.9; age at index: 64; days to birth: -23674; days to death: 444; ethnicity: not hispanic or latino; gender: male; race: black or african american; vital status: Dead; year of birth: 1949; age at diagnosis: 23674; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 164.0; icd 10 code: C71.1; last known disease status: not reported; morphology: 9440/3; primary diagnosis: Glioblastoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Frontal lobe; synchronous malignancy: No; tissue or organ of origin: Frontal lobe; tumor grade: Not Reported; year of diagnosis: 2013; treatment or therapy: yes; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 71; initial weight: 440.0; oct embedded: false; preservation method: Unknown; sample id: 5012c42c-3fbb-4e0a-abbb-78dcc6e03d9a; sample submitter id: TCGA-06-A7TK-01A; portion id: cee87dda-cb07-4248-86aa-9de5000d4741; portion submitter id: TCGA-06-A7TK-01A-21; slide id: 5d737003-fce8-44d6-8483-841394826b6b; slide submitter id: TCGA-06-A7TK-01A-02-TS2; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 15.0; percent stromal cells: 15.0; percent tumor cells: 70.0; percent tumor nuclei: 75.0; section location: TOP;